stay updated with our newsletter

Subscribe
Facebook Twitter Linkedin

The Aging Female Heart: Beyond the Male Model of Cardiovascular Care

Heart health remains a universal concern, but women face a distinct set of structural, biological and psychosocial influences that drive cardiovascular risk. As female patients transition through menopause—and the protective effects of estrogen drop—their risks amplify. Women require a personalized approach to cardiovascular care—and research highlights the effectiveness of natural interventions and evidence-based supplements in fortifying the female heart, enhancing whole-body wellness and promoting longevity.

The Female Heart: Why Gender Matters

Women are uniquely vulnerable to cardiovascular disease, often experiencing worse outcomes than men. While overall incidence is lower until menopause, women are more likely to die after a first heart attack or stroke and are frequently undertreated compared to men. “This is often due to lower recognition of symptoms and delayed care as a result of sometimes-vague symptom presentation,” says Sarah Hung, ND, MSOM, L.Ac. “Additionally, women have not historically been well represented in clinical trials of heart-related conditions.”

Although the default male model of cardiology has long directed conventional approaches, women navigate an entirely different landscape, and sex-based variations in anatomy, biology and disease progression demands personalized, gender-specific strategies. Anatomically, female hearts and blood vessels are smaller and more susceptible to developing plaques. While men present with heavily calcified plaques, women have less calcified plaques that are prone to rupture. Women are predisposed to microvascular problems and exhibit greater symptom burden and increased functional disability. They also experience a higher prevalence of non-obstructive coronary artery disease, rather than classic large-vessel blockages typically seen in men—generally harder to detect, interpret and diagnose on a standard angiogram.1, 2, 3, 4, 5, 6

Biologically, menopause is a massive cardiovascular pivot point. Estrogen is protective for premenopausal women, and declining levels are associated with unfavorable shifts in LDL and HDL ratios, endothelial dysfunction, systemic inflammation, hypertension and a rise in arterial stiffness. And although women have lower overall rates of heart disease than men, their risk increases dramatically after menopause. Obstetric history and complications like preeclampsia and gestational diabetes are associated with cardiometabolic syndrome later in life, and various comorbidities— including diabetes and hypertension—pose a significantly greater cardiovascular threat to women than to men.7, 8, 9, 10, 11, 12, 13, 14

Besides biological differences, psychosocial factors play a central role. Older women are more likely to live alone than older men, and this social isolation heightens their risk of heart disease. Women not only have a higher prevalence of stress-associated mood and anxiety disorders, they’re also more vulnerable to adverse cardiovascular events related to these.15, 16, 17, 18, 19

And unlike the crushing chest pain generally experienced by men, women tend to present with varied and subtle symptoms such as dizziness, fatigue, jaw pain or nausea which can lead to delayed diagnosis. One study of recent heart attack patients found women and their healthcare providers were significantly less likely to attribute their symptoms to heart disease, in comparison with men. Most troubling: current projections show nearly 60 percent of women will suffer from some form of cardiovascular disease by 2050.20, 21, 22, 23, 24, 25

A Personalized Protocol—Designed for Women

The bottom line: female cardiovascular care requires a targeted, gender-specific plan. “A personalized approach is especially important when considering the protective role that estrogen plays in cardiovascular health prior to menopause,” says Hung. Along with technologies like wearables and sensors and advanced diagnostic testing, integrative strategies that incorporate nutrition, lifestyle changes and science-backed supplements not only fortify the female heart, but also support whole-body wellness and protect against other age-related conditions. Here’s what the research shows:

Diet and nutrition

As heart disease risk magnifies after menopause, women benefit more than men from dietary modifications. A plant-based diet is linked with significant reductions in cardiovascular events, coronary heart disease and heart failure in women and in one study, women who adhered to the Mediterranean Diet had a 25 percent lower cardiovascular risk. Women are more vulnerable than men to the adverse effects of elevated glucose, so blood sugar control is vital. Boosting fiber consumption normalizes glucose levels, improves lipid profiles and enhances gut microbial diversity—also known to reduce rates of heart disease. High blood pressure is strongly associated with heart failure and death in women, and studies show the DASH diet lowers systolic and diastolic blood pressure and significantly decreases cardiovascular disease risk, with measurably pronounced effects in women.26, 27, 28, 29, 30, 31

Exercise and Movement

Regular physical activity has been shown to decrease blood pressure, improve insulin sensitivity and lipid profiles, dampen inflammation, enhance endothelial function, promote the release of nitric oxide and minimize stress. Physical activity provides greater cardiovascular benefits for women, often requiring less time to achieve similar heart-healthy gains. One observational study found women who exercised consistently had a 36 percent lower risk for a fatal heart attack, stroke or other cardiovascular event, compared to 14 percent for men. They also needed shorter bouts of moderate aerobic workouts for the same results—about half the time required for men. These differences applied to body weight exercises as well: women who did strength training had a 30 percent reduced risk of cardiovascular-related death compared to 11 percent for men.32, 33, 34, 35, 36, 37

Lessen Stress

Women are disproportionally susceptible to the effects of stress, and studies illustrate the profound role of emotional factors on female cardiovascular health. Rates of stress-associated mental disorders, including depression, anxiety and PTSD, as well as childhood adversity, are nearly double in women, and research suggests depression and early life stress are powerful predictors of heart disease. In one study, myocardial ischemia provoked by mental stress was twice as common in women than men, and other stress-related cardiovascular conditions were overwhelmingly more frequent. Specific stress-relief practices—like relaxation techniques, strong social connections, support networks and mindfulness-based stress reduction (MBSR)—are essential for women, who also tend to adhere to a regular practice compared to men.38, 39, 40, 41, 42, 43, 44

Optimize Sleep

Disrupted sleep is implicated in cardiovascular events and mortality in both sexes, but women are especially vulnerable. Hormonal shifts impact circadian rhythms and sleep cycles, and poor sleep quality during and after menopause affects up to 60 percent of women. They’re also more likely to experience sleep disturbances following exposure to stress. Restless legs syndrome and other sleep disorders are almost twice as prevalent in women than men, and up to 67 percent of postmenopausal women have obstructive sleep apnea. Disrupted sleep is strongly associated with adverse heart effects in women: in one study, those with high insomnia scores had a 38 percent greater risk of coronary heart disease and a 27 percent increase in cardiovascular disease. Natural supplements like L-theanine, magnesium glycinate, and melatonin can ameliorate sleep disturbances and nocturnal awakenings related to menopause, stress and sleep disorders.45, 46, 47, 48, 49, 50

Along with diet and lifestyle modifications, evidence-based nutrients and botanicals add a layer of protection, especially when risk factors are elevated. “These may include a family history of heart disease, chronic inflammation, insulin resistance, toxin exposure, poor diet, excess alcohol use and sedentary behavior,” says Hung. “Supplementation helps a patient receive concentrated dosages of nutrients and plant compounds in quantities that would be hard to obtain from food alone.”

Science-Backed Supplements for the Female Heart

Resveratrol

Resveratrol, a polyphenol found in grapes and red wine, has a range of benefits specific to the female heart. Its antioxidant and anti-inflammatory effects are well documented, and in research, resveratrol has been shown to improve endothelial function, increase nitric oxide production, slow the development of atherosclerotic plaques and protect vascular health. Studies also point to its lipid-lowering properties, with meta-analyses suggesting resveratrol significantly reduces triglycerides, LDL-C and total cholesterol levels. Other research demonstrates resveratrol’s ability to decrease systolic blood pressure.51, 52, 53, 54, 55, 56, 57, 58

As a phytoestrogen, resveratrol has added benefits during menopause. “Because it is a selective estrogen receptor modulator (or SERM), it may exhibit anti-estrogenic effects in some cases,” says Hung. “As a result, research shows resveratrol may reduce the risk of certain cancers such as breast cancer and help preserve bone health, mimicking some of the protective actions of estrogen.” Various studies confirm the ability of resveratrol to protect against postmenopausal health conditions, with studies noting improvements in memory, cognitive function, bone mineral density and mood fluctuations in postmenopausal women. Additional research highlights its neuroprotective and anticancer properties, and resveratrol is thought to be a promising therapeutic alternative to conventional HRT.59, 60, 61, 62, 63, 64

Along with resveratrol, other nutrients have been shown to support women’s cardiovascular health. EGCG, a potent antioxidant found in green tea mitigates oxidative stress and inflammation, and studies demonstrate its ability to lower LDL cholesterol, promote vasodilation, reduce blood pressure and enhance overall vascular function 65, 66, 67, 68, 69

MK-7 and D3

MK-7, a highly bioavailable form of vitamin K derived from natural fermentation, is important for the female heart: in research, MK-7 inhibited vascular calcification, decreased arterial stiffness and improved blood pressure in postmenopausal women, and studies suggest it can impede the onset of atherosclerosis. Vitamin D3 is crucial for heart health and deficiencies are linked to increased risk of cardiovascular disease, hypertension and heart failure. Additionally, vitamin D3 works synergistically with MK-7 and in studies, a combination of the two appears to slow the progression of coronary artery calcification and may reduce cardiovascular events such as acute myocardial infarction, coronary revascularization and all-cause death. 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80

Additional Supportive Nutrients

A targeted formula that blends MK-7 and vitamin D3 with supportive nutrients offers comprehensive protection. Grapeseed extract, CoQ10, L-carnitine, and hawthorn are top considerations. Research suggests grapeseed extract can significantly lower heart rate and systolic blood pressure, decrease inflammation, limit LDL oxidation, inhibit platelet aggregation and slow the development of atherosclerosis. CoQ10 and L-carnitine are essential for cellular energy production in cardiac muscle, and hawthorn extract has been shown to enhance blood flow and heart muscle function.81, 82, 83, 84, 85, 86, 87, 88, 89, 90

Click on the image above to download a complimentary copy of our new Heart Health eBook.

References

  1. Betai D et al. Gender Disparities in Cardiovascular Disease and Their Management: A Review. Cureus. 2024 May 5;16(5):e59663.
  2. Kothawade K, Bairey Merz CN. Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol. 2011 Aug;36(8):291-318.
  3. Wentzel JJ et al. Sex-related differences in plaque characteristics and endothelial shear stress related plaque-progression in human coronary arteries. Atherosclerosis. 2022 Feb;342:9-18.
  4. Pilote L et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ. 2007 Mar 13;176(6):S1-44.
  5. Campbell KR. Women and Cardiovascular Disease : Addressing Disparities in ColleCare. World Scientific; [ Feb; 2023 ]. 2015. Women and cardiovascular disease: addressing disparities in care.
  6. Huebschmann AG et al. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019 Oct;62(10):1761-1772.
  7. Raj A et al. The Impact of Menopause on Cardiovascular Aging: A Comprehensive Review of Androgen Influences. Cureus. 2023 Aug 16;15(8):e43569.
  8. Regensteiner JG, Reusch JEB. Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and Diabetes: JACC Focus Seminar 4/7. J Am Coll Cardiol. 2022 Apr 19;79(15):1492-1505.
  9. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008 Jun;60(2):210-41.
  10. Yanes LL, Reckelhoff JF. Postmenopausal hypertension. Am J Hypertens. 2011 Jul;24(7):740-9.
  11. Liu T et al. Lifetime Adverse Pregnancy Outcome History and Cardiovascular Risk. Hypertension. 2026 Mar 20:10.1161/HYPERTENSIONAHA.125.25916.
  12. Fraser A et al. Ten-Year Cardiovascular Disease Risk Trajectories by Obstetric History: A Longitudinal Study in the Norwegian HUNT Study. J Am Heart Assoc. 2022 Jan 18;11(2):e021733.
  13. Wang Z et al. Prevalence of diabetes and hypertension and their interaction effects on cardio-cerebrovascular diseases: a cross-sectional study. BMC Public Health. 2021 Jun 25;21(1):1224.
  14. Kumar A, McCullough L. Cerebrovascular disease in women. Ther Adv Neurol Disord. 2021 Jan 27;14:1756286420985237.
  15. Mehta LS et al. Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association. Circulation. 2023; 147:19.
  16. Lindley KJ et al. Socioeconomic Determinants of Health and Cardiovascular Outcomes in Women: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Nov 9;78(19):1919-1929.
  17. Freeborne N et al. Perceived social support and the risk of cardiovascular disease and all-cause mortality in the Women’s Health Initiative Observational Study. Menopause. 2019;26:698-707.
  18. Teshale AB et al. Gender-Specific Population Attributable Fractions for Cardiovascular Disease and All-Cause Mortality Associated with Living Arrangement in Community-Dwelling Older People. J Gen Intern Med. 2025 Aug;40(11):2613-2623.
  19. Ebong IA et al. The Role of Psychosocial Stress on Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jul 16;84(3):298-314.
  20. Ferry AV et al. Presenting Symptoms in Men and Women Diagnosed With Myocardial Infarction Using Sex-Specific Criteria. J Am Heart Assoc. 2019 Sep 3;8(17):e012307.
  21. Lichtman JH et al. Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients). Circulation. 2018 Feb 20;137(8):781-790.
  22. Cushman M et al. Ten-Year Differences in Women’s Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association. Circulation. 2021 Feb 16;143(7):e239-e248.
  23. Palaniappan LP et al. 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2026 Jan 21
  24. Tsao CW et al. Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association. Circulation. 2023;147:e93–e621.
  25. Joynt Maddox KE et al. Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association. Circulation. 2026 Mar 31;153(13):e1061-e1077.
  26. Glenn AJ et al. Relationship Between a Plant-Based Dietary Portfolio and Risk of Cardiovascular Disease: Findings From the Women’s Health Initiative Prospective Cohort Study. J Am Heart Assoc. 2021 Aug 17;10(16):e021515.
  27. Satija A, Hu FB. Plant-based diets and cardiovascular health. Trends Cardiovasc Med. 2018 Oct;28(7):437-441
  28. Guasch-Ferré M et al. Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults. J Am Coll Cardiol. 2022 Jan 18;79(2):101-112.
  29. Ahmad S et al. Assessment of Risk Factors and Biomarkers Associated With Risk of Cardiovascular Disease Among Women Consuming a Mediterranean Diet. JAMA Netw Open. 2018 Dec 7;1(8):e185708.
  30. Witkowski M et al. Gut Microbiota and Cardiovascular Disease. Circ Res. 2020 Jul 31;127(4):553-570.
  31. Hussain BM et al. Concordance Between DASH Diet and Coronary Artery Calcification: Results From the Mediators of Atherosclerosis in South Asians Living in America (MASALA) Prospective Cohort Study. AJPM Focus. 2024 Oct 16;4(1):100288.
  32. Nystoriak MA, Bhatnagar A. Cardiovascular Effects and Benefits of Exercise. Front Cardiovasc Med. 2018 Sep 28;5:135.
  33. Wang Y, Xu D. Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis. 2017 Jul 5;16(1):132.
  34. Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017 Mar 1;2(1):e000143.
  35. Cerqueira É et al. Inflammatory Effects of High and Moderate Intensity Exercise-A Systematic Review. Front Physiol. 2020 Jan 9;10:1550.
  36. Gao J et al. Physical Exercise Protects Against Endothelial Dysfunction in Cardiovascular and Metabolic Diseases. J Cardiovasc Transl Res. 2022 Jun;15(3):604-620.
  37. Ji H et al. Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality. J Am Coll Cardiol. 2024 Feb 27;83(8):783-793.
  38. Vaccarino V, Bremner JD. Behavioral, emotional and neurobiological determinants of coronary heart disease risk in women. Neurosci Biobehav Rev. 2017 Mar;74(Pt B):297-309.
  39. Shah AJ et al. Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events. J Am Heart Assoc. 2014 Jun 18;3(3):e000741.
  40. Xu X et al. Sex differences in perceived stress and early recovery in young and middle-aged patients with acute myocardial infarction. Circulation. 2015 Feb 17;131(7):614-23.
  41. Korkeila J et al. Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease. Heart. 2010 Feb;96(4):298-303.
  42. Stewart AL et al. Women’s heart health at mid-life: what is the role of psychosocial stress? Women’s Midlife Health. 2018 Jul 6;4:11.
  43. Vaccarino V et al. Sex Differences in Mental Stress-Induced Myocardial Ischemia in Patients With Coronary Heart Disease. J Am Heart Assoc. 2016 Aug 24;5(9):e003630.
  44. Helman TJ et al. The sex-dependent response to psychosocial stress and ischaemic heart disease. Front Cardiovasc Med. 2023 Apr 21;10:1072042.
  45. Jehan S et al. Sleep Disorders in Postmenopausal Women. J Sleep Disord Ther. 2015 Aug;4(5):212. Epub 2015 Aug 25.
  46. Seeman MV. Why Are Women Prone to Restless Legs Syndrome? Int J Environ Res Public Health. 2020 Jan 6;17(1):368.
  47. Jehan S et al. Obstructive Sleep Apnea: Women’s Perspective. J Sleep Med Disord. 2016;3(6):1064. Epub 2016 Aug 25.
  48. Kapsimalis F, Kryger M. Sleep breathing disorders in the U.S. female population. J Womens Health (Larchmt). 2009 Aug;18(8):1211-9.
  49. Sands-Lincoln M et al. Sleep duration, insomnia, and coronary heart disease among postmenopausal women in the Women’s Health Initiative. J Womens Health (Larchmt). 2013 Jun;22(6):477-86.
  50. Thurston RC et al. Trajectories of Sleep Over Midlife and Incident Cardiovascular Disease Events in the Study of Women’s Health Across the Nation. Circulation. 2024 Feb 13;149(7):545-555.
  51. Bonnefont-Rousselot D. Resveratrol and Cardiovascular Diseases. Nutrients. 2016 May 2;8(5):250.
  52. Breuss JM et al. Resveratrol and Its Effects on the Vascular System. Int J Mol Sci. 2019 Mar 27;20(7):1523.
  53. Godos J et al. Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota. Front Pharmacol. 2024 Mar 18;15:1368949.
  54. Parsamanesh N et al. Resveratrol and endothelial function: A literature review. Pharmacol Res. 2021 Aug;170:105725.
  55. Cao X et al. The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrients. 2022 Sep 11;14(18):3755.
  56. Akbari M et al. The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis. 2020 Feb 17;19(1):25.
  57. Fogacci F et al. Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr. 2019;59(10):1605-1618.
  58. Liu Y et al. Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clin Nutr. 2015 Feb;34(1):27-34.
  59. Bagchi D et al. Benefits of resveratrol in women’s health. Drugs Exp Clin Res. 2001;27(5-6):233-48.
  60. Chen MN et al. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric. 2015 Apr;18(2):260-9.
  61. Wu W et al. Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis. Front Pharmacol. 2025 Jul 23;16:1588284.
  62. Cooney C et al. The effect of Resveratrol on menopausal symptoms: a systematic review. Proceedings of the Nutrition Society. 2022;81(OCE4):E121.
  63. Tu W et al. Does resveratrol improve cognition in humans? A scientometric study to an in-depth review. CNS Neurosci Ther. 2023 Sep;29(9):2413-2429.
  64. Wong RH et al. Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial. J Bone Miner Res. 2020 Nov;35(11):2121-2131.
  65. Eshraghi R et al. Cardioprotective and Anti-Hypertensive Effects of Epigallocatechin Gallate: Novel Insights Into Biological Evidence. J Clin Hypertens (Greenwich). 2025 Jun;27(6):e70036.
  66. Niu L et al. Dietary (-)-Epigallocatechin Gallate (EGCG): State-of-the-Art Advances in Bioactivities, Bioavailability Enhancement Strategies, and Applications in Nutrition and Health. Nutrients. 2026 Jan 19;18(2):317.
  67. Zhang B et al. Epigallocatechin gallate mediated sandwich-like coating for mimicking endothelium with sustained therapeutic nitric oxide generation and heparin release. Biomaterials. 2021 Feb;269:120418.
  68. Li H et al. Cardioprotective Effects of the Natural Antioxidant Epigallocatechin Gallate. Antioxidants (Basel). 2025 Nov 27;14(12):1417.
  69. Widlansky ME et al. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr. 2007 Apr;26(2):95-102.
  70. Ikari Y et al. Impact of menaquinone-4 supplementation on coronary artery calcification and arterial stiffness: an open label single arm study. Nutr J. 2016 May 12;15(1):53.
  71. de Vries F et al. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women. Nutrients. 2025 Feb 27;17(5):815.
  72. Knapen MH et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost. 2015 May;113(5):1135-44.
  73. Scheiber D et al. High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification. Nutrients. 2015 Aug 18;7(8):6991-7011.
  74. Sato T et al. MK-7 and Its Effects on Bone Quality and Strength. Nutrients. 2020 Mar 31;12(4):965.
  75. Vik H. Highlighting The Substantial Body Of Evidence Confirming The Importance Of Vitamin K2 As A Cardio-Support Nutrient, And How The Right K2 Makes All The Difference. Integr Med (Encinitas). 2019 Dec;18(6):24-28.
  76. Haider F et al. Vitamin D and Cardiovascular Diseases: An Update. Cureus. 2023 Nov 30;15(11):e49734.
  77. Rusu ME et al. Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women: An Up-to-Date Comprehensive Review of Clinical Studies. Nutrients. 2024 Jul 20;16(14):2356.
  78. Braam LA et al.  Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost. 2004 Feb;91(2):373-80.
  79. Hasific S et al. Effects of Vitamin K2 and D Supplementation on Coronary Artery Disease in Men: A RCT. JACC Adv. 2023 Nov 24;2(9):100643.
  80. Diederichsen ACP et al. Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. Circulation. 2022 May 3;145(18):1387-1397.
  81. Feringa HH et al. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc. 2011 Aug;111(8):1173-81.
  82. Gupta M et al. Grape seed extract: having a potential health benefits. J Food Sci Technol. 2020 Apr;57(4):1205-1215.
  83. Draijer R et al. Consumption of a polyphenol-rich grape-wine extract lowers ambulatory blood pressure in mildly hypertensive subjects. Nutrients. 2015 Apr 30;7(5):3138-53.
  84. Gutierrez-Mariscal FM et al.  Coenzyme Q10 and Cardiovascular Diseases. Antioxidants (Basel). 2021 Jun 3;10(6):906.
  85. Rabanal-Ruiz Y et al. The Use of Coenzyme Q10 in Cardiovascular Diseases. Antioxidants (Basel). 2021 May 10;10(5):755.
  86. Elantary R, Othman S. Role of L-carnitine in Cardiovascular Health: Literature Review. Cureus. 2024 Sep 26;16(9):e70279.
  87. Demarquoy J. Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota. Nutrients. 2024 Dec 9;16(23):4244.
  88. Wang J et al. Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach. Evid Based Complement Alternat Med. 2013;2013:149363.
  89. Lu M et al. Advances in the study of the vascular protective effects and molecular mechanisms of hawthorn (Crataegus anamesa Sarg.) extracts in cardiovascular diseases. Food Funct. 2023 Jul 3;14(13):5870-5890.
  90. Tassell MC et al. Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease. Pharmacogn Rev. 2010 Jan;4(7):32-41.

 

 

 

 

Related Articles